Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Breast 1

Conditions

Motor Activity 2Pancreatic Neoplasms 1Neoplasms 1Esophageal Neoplasms 1Breast Neoplasms 1

Interventions

Specimen Handling 613pembrolizumab 563Magnetic Resonance Spectroscopy 536Carboplatin 425Cisplatin 375Cyclophosphamide 373Biopsy 357Paclitaxel 306Gemcitabine 303Nivolumab 300Radiotherapy 260Bevacizumab 234Dexamethasone 209fludarabine 205Docetaxel 187durvalumab 182atezolizumab 173Oxaliplatin 172venetoclax 168Fluorouracil 166Rituximab 165Pemetrexed 163Capecitabine 158Doxorubicin 157Radiation 155Radiosurgery 148Etoposide 137Leucovorin 133Ipilimumab 133Lenalidomide 131

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Nutritional Status × 90 days × Clear all
NCT06872515 2026-05-26

Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)

University of Pittsburgh

Phase NA Recruiting
20 enrolled
Gastrointestinal

Esophageal Neoplasms, Motor Activity

NCT05912257 2026-05-20

NOSH

VA Office of Research and Development

Phase NA Recruiting
188 enrolled
Tumor-Agnostic

Neoplasms

NCT07467824 2026-04-16

PREACT

European University Miguel de Cervantes

Phase NA Recruiting
66 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT06712797 2026-03-13

PANTHER-PIC

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Active not recruiting
24 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡